HOME >> BIOLOGY >> NEWS
Fox Chase Cancer Center's Alfred Knudson Jr. named 2004 Kyoto Prize winner

Cancer researcher Alfred G. Knudson Jr., M.D., Ph.D., (pronounced ka-nud'-son) of Fox Chase Cancer Center, Philadelphia, Pa., has been named winner of a prestigious Kyoto Prize for 2004. The Kyoto Prize is considered among the world's leading awards for lifetime achievement and is given to those who have "contributed significantly to mankind's betterment." Knudson will receive a cash gift of about $450,000 (50 million yen), the 20 karat gold Kyoto Prize Medal and a diploma at the Kyoto Prize Ceremony in Kyoto, Japan on November 10, 2004.

The Inamori Foundation selects three Kyoto Prize (www.kyotoprize.org) laureates annually for significant contributions to the scientific, cultural and spiritual development of mankind in the fields of advanced technology, basic sciences, arts and philosophy.

Knudson will receive the basic sciences prize for his role in establishing the theory of tumor suppressor genes, which opened a new horizon in modern cancer genetics, and made a pivotal contribution to major subsequent research developments in understanding human cancer.

"Today, we are rushing ahead with incredible scientific and technological achievements, while inquiry into our spiritual nature lags deplorably," said Dr. Kazuo Inamori, founder and president of the Inamori Foundation. "It is my hope that the Kyoto Prize will encourage balanced development of both our scientific and our spiritual sides, and hence provide impetus toward the structuring of new philosophical paradigms."

This year's other Kyoto Prize laureates will be:

  • Dr. Alan Curtis Kay, a computer scientist and senior fellow at Hewlett-Packard Co., whose work at Stanford University and the Xerox Palo Alto Research Center in the 1960s and '70s led the paradigm shift away from mainframe computing and opened the door for the personal computer revolution; and
  • Prof. Jurgen Habermas, a philosopher at the University of Frank
    '"/>


Contact: Karen C. Mallet
k_carter@fccc.edu
215-728-2700
Fox Chase Cancer Center
11-Jun-2004


Page: 1 2 3 4

Related biology news :

1. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
2. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
3. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
4. Fox Chase Cancer Center researchers identify significant smoking-induced genetic alteration
5. Fox Chase Cancer Center research reveals how COX-2 causes ovarian cancer
6. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
7. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
8. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
9. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
10. Fox Chase Cancer Center researchers make significant discovery about function of p53
11. Fox Chase Cancer Center receives grant to study possible link between measles vaccine and autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. announced ... that provides patent development support for early stage startups. The investment will support ... ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology. , ...
(Date:4/18/2020)... ... April 16, 2020 , ... SIRION Biotech GmbH , a world ... it will present a company update on its work expediting gene therapy research and ... on April 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also ...
(Date:4/16/2020)... , ... April 15, 2020 , ... ... working cell banks and hMSC bioprocess systems, announces that the Medical Technology Enterprise ... at MTEC’s 4th Annual Membership Meeting in March. The Regenerative Medicine (RegenMed) biomanufacturing ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... WEST CHESTER, Ohio (PRWEB) , ... April 21, ... ... availability of Biophen™ FXIII chromogenic method for determination of FXIII. , Aniara Diagnostica, ... has strengthened its commitment to meeting today’s highest standards for product quality and ...
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Innovation Research (SBIR) program to support the expansion of its digital health platform ... which conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government ...
(Date:4/7/2020)... ... 06, 2020 , ... Red Nucleus, a leading provider of ... the release of at-home virtual learning resources for all client partners. , “With ... of our employees as we continue to implement measures to safeguard the well-being ...
(Date:4/1/2020)... (PRWEB) , ... March 30, 2020 , ... ... and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to bring ... pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an Emergency ...
Breaking Biology Technology:
Cached News: